-
-
-
-
-
-
-
H.C. Wainwright Downgrades Apellis Pharmaceuticals (APLS) to Neutral
-
-
-
-
-
-
-
Apellis Pharmaceuticals (APLS) PT Raised to $41 at Morgan Stanley
-
-
-
-
-
-
-
Biogen to acquire Apellis Pharmaceuticals for $5.6 billion or $41/sh plus CVR
-
-
-
-
-
-
-
TTM Technologies, Dutch Bros among companies joining S&P MidCap 400; Others join S&P SmallCap 600
-
-
-
-
-
-
-
Here's the list of top biotech stocks to own for 2026
-
-
-
-
-
-
-
Apellis Pharmaceuticals (APLS) PT Raised to $29 at BofA Securities
-
-
-
-
-
-
-
Apellis Pharmaceuticals (APLS) PT Raised to $22 at Scotiabank
-
456,758 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

